insights_auto
Why is KLRS down 3.76%?
Dive Deeperchevron_right
KLRS:NASDAQ
Kalaris Therapeutics Inc
$2.56
arrow_downward
-3.76%(-0.10) 1D
Oct 7, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KLRS...
Open
$2.59
High
$2.69
Low
$2.53
Mkt. cap
60.94M
Avg. vol.
70.61K
Volume
0.00
52-wk high
$11.88
52-wk low
$2.51
EPS
-$2.09
Beta
0.42
Shares outstanding
23.80M
No. of employees
20
Open
$2.59
High
$2.69
Low
$2.53
Mkt. cap
60.94M
Avg. vol.
70.61K
Volume
0.00
52-wk high
$11.88
52-wk low
$2.51
EPS
-$2.09
Beta
0.42
Shares outstanding
23.80M
No. of employees
20
News stories
From web sources and news partners
BigGo Finance
·
40 minutes ago
October Jitters vs. Record Highs: What 20 Years of S&P 500 Data Says About Buying Now
TradingView
·
50 minutes ago
Why Are Nasdaq, Dow Futures Falling Premarket? MU, TSM, APLD, IONQ, HOOD, BULL, SLS In Focus
巴士的報
·
3 hours ago
U.S. stocks close lower
marketscreener.com
·
5 hours ago
S&P 500 index rose slightly after the Stockholm exchange closed on Wednesday
About Kalaris Therapeutics Inc
CEO-
Employees20
Founded2019
HeadquartersBerkeley Heights, New Jersey, United States
SectorBiotechnology
Websitekalaristx.com